Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies

Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies

<p>Abstract</p> <p>Background</p> <p>Human cytomegalovirus infection is associated with a variety of pathological conditions including retinitis, pneumonia, hepatitis and encephalitis that may be transmitted congenitally, horizontally and parenterally and occurs both as...

Full description

Bibliographic Details
Main Authors:	Alter Harvey J, Drew W Lawrence, Exner Maurice, Ching Kathryn H, Issa Alexandra T, Burbelo Peter D, Iadarola Michael J
Format:	Article
Language:	English
Published:	BMC 2009-05-01
Series:	Virology Journal
Online Access:	http://www.virologyj.com/content/6/1/45

Similar Items

Serologic evaluation of cytomegalovirus (CMV), Toxoplasma gondii and Brucella in schizophrenia patients
by: Seyed Shahab Banihashem, et al.
Published: (2023-05-01)

Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies
by: Nicolle H. R. Litjens, et al.
Published: (2017-09-01)

Kinetics of IgG antibody to cytomegalovirus (CMV) after birth and seroprevalence of anti-CMV IgG in Chinese children
by: Chen Jie, et al.
Published: (2012-12-01)

Cytomegalovirus (CMV) Infection and Latency
by: Christine M. O’Connor
Published: (2021-03-01)

Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
by: Posner Gary H, et al.
Published: (2011-01-01)

Challenges in Cytomegalovirus (CMV) Retinitis Management
by: Denisa Rosati, et al.
Published: (2019-09-01)

Cytomegalovirus infection of brain tumors and CMV immunotherapy
by: Mykola I. Lisianyi, et al.
Published: (2022-09-01)

Cytomegalovirus (CMV) seroprevalence in the adult population of Germany.
by: Raskit Lachmann, et al.
Published: (2018-01-01)

Cytomegalovirus (CMV) epitope-specific CD4(+) T cells are inflated in HIV(+) CMV(+) subjects
by: Abana, CO, et al.
Published: (2017)

Monitoring of cytomegalovirus (CMV) infection in solid organ transplant recipients: quantitation of CMV DNAemia by two real-time polymerase chain reaction assays
by: Angela Chiereghin, et al.
Published: (2016-10-01)

Congenital cytomegalovirus infection in the absence of maternal CMV-IgM antibodies: a case report
by: S. Fanaro, et al.
Published: (2021-02-01)

Detection of cytomegalovirus (CMV) by digital PCR in stool samples for the non-invasive diagnosis of CMV gastroenteritis
by: Jia Gu, et al.
Published: (2022-11-01)

Taking a step beyond serology: progress in the search for a biomarker predicting the risk of maternal-fetal transmission of cytomegalovirus (CMV)
by: Mark R. Schleiss
Published: (2024-03-01)

Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
by: Swetha Pinninti, et al.
Published: (2023-10-01)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
by: Hyeyoung Lee, et al.
Published: (2017-01-01)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients.
by: Jong Man Kim, et al.
Published: (2015-01-01)

Advancing Luciferase-Based Antibody Immunoassays to Next-Generation Mix and Read Testing
by: Peter D. Burbelo, et al.
Published: (2023-02-01)

Prevalence of asymptomatic cytomegalovirus (CMV) infection in newborns in northeast Florida
by: Rana Alissa, et al.
Published: (2024-01-01)

Human cytomegalovirus (CMV) dysregulates neurodevelopmental pathways in cerebral organoids
by: Ece Egilmezer, et al.
Published: (2024-03-01)

Colonic perforation in a kidney recipient with Cytomegalovirus (CMV) colitis
by: F Oliaei, et al.
Published: (2005-01-01)

Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen
by: Matthew Bates, et al.
Published: (2016-07-01)

Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection
by: Mark R. Schleiss, et al.
Published: (2020-09-01)

Diagnostic usefulness of the cytomegalovirus (CMV)-specific T cell-based assay for predicting CMV infection after kidney transplant
by: Taeeun Kim, et al.
Published: (2020-03-01)

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
by: Paul V. Lehmann, et al.
Published: (2012-04-01)

Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells
by: Sarah E. Jackson, et al.
Published: (2017-06-01)

SEROLOGICAL CMV SCREENING IN WOMEN OF REPRODUCTIVE AGE AND IN PREGNANT WOMEN
by: Zhivka Stoykova
Published: (2019-11-01)

Cytokines expression in primary and non-primary maternal cytomegalovirus (CMV) infection
by: Faizal, Nur Fazlin Akmal Muhammad
Published: (2022)

Direct visualization of the immune response to cytomegalovirus (CMV) following renal transplantation.
by: Jayawardene, SA, et al.
Published: (2002)

An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities.
by: Ran He, et al.
Published: (2011-01-01)

Droplet Digital PCR (ddPCR) Does Not Enhance the Sensitivity of Detection of Cytomegalovirus (CMV) DNA in Newborn Dried Blood Spots Evaluated in the Context of Newborn Congenital CMV (cCMV) Screening
by: Nelmary Hernandez-Alvarado, et al.
Published: (2023-12-01)

Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection
by: Cui Xiaohong, et al.
Published: (2008-04-01)

Impact of Cytomegalovirus (CMV) on an Academic Pediatric Infectious Diseases Outpatient Clinic Referral Population, 2005–2020: Will the Advent of Universal Congenital CMV (cCMV) Screening Change Clinical Practice Referral Patterns?
by: Katelyn J. Rypka, et al.
Published: (2024-02-01)

Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
by: Monica Miele, et al.
Published: (2021-03-01)

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
by: Samantha Barnes, et al.
Published: (2020-11-01)

Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation
by: Ian Pang, et al.
Published: (2022-01-01)

CLINICAL MANIFESTATIONS AND CD4 COUNT CHARACTERISTICS OF PATIENTS WITH CYTOMEGALOVIRUS (CMV) RETINITIS
by: Yunneke Renna Xaverina, et al.
Published: (2022-09-01)

The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review
by: Hassan Al Mana, et al.
Published: (2019-10-01)

A succinct synthesis of valganciclovir hydrochloride – A cytomegalovirus (CMV) retinitis inhibitor
by: Karrothu Srihari Babu
Published: (2011-01-01)

Examining the species-specificity of rhesus macaque cytomegalovirus (RhCMV) in cynomolgus macaques.
by: Angie K Marsh, et al.
Published: (2015-01-01)

The prevalence of Cytomegalovirus (CMV) infection among infants in Hospital Universiti Sains Malaysia
by: Z.N. Salmuna, et al.
Published: (2020-12-01)